Header Logo

Connection

James Mulshine to Anticarcinogenic Agents

This is a "connection" page, showing publications James Mulshine has written about Anticarcinogenic Agents.
Connection Strength

0.803
  1. Chemoprevention of head and neck cancer. Clin Adv Hematol Oncol. 2005 Oct; 3(10):763-5.
    View in: PubMed
    Score: 0.256
  2. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res. 2000 Aug; 6(8):3015-24.
    View in: PubMed
    Score: 0.179
  3. Fostering chemopreventive agent development: how to proceed? J Cell Biochem Suppl. 1995; 22:254-9.
    View in: PubMed
    Score: 0.122
  4. Growth factors and other targets for rational application as intervention agents. Adv Exp Med Biol. 1992; 320:81-8.
    View in: PubMed
    Score: 0.099
  5. Lung cancer evolution to preinvasive management. Clin Chest Med. 2002 Mar; 23(1):37-48.
    View in: PubMed
    Score: 0.050
  6. Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors. Clin Cancer Res. 2000 Sep; 6(9):3636-45.
    View in: PubMed
    Score: 0.045
  7. Scientific basis for cancer prevention. Intermediate cancer markers. Cancer. 1993 Aug 01; 72(3 Suppl):978-83.
    View in: PubMed
    Score: 0.028
  8. Candidate biomarkers for application as intermediate end points of lung carcinogenesis. J Cell Biochem Suppl. 1992; 16G:183-6.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.